0001209191-20-041644.txt : 20200708 0001209191-20-041644.hdr.sgml : 20200708 20200708123041 ACCESSION NUMBER: 0001209191-20-041644 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200706 FILED AS OF DATE: 20200708 DATE AS OF CHANGE: 20200708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fust Matthew K CENTRAL INDEX KEY: 0001397266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 201017812 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-06 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001397266 Fust Matthew K C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 1 0 0 0 Common Stock 2020-07-06 4 M 0 6181 21.00 A 19731 D Common Stock 2020-07-06 4 S 0 6181 90.00 D 13550 D Stock Option (Right to Buy) 21.00 2020-07-06 4 M 0 6181 0.00 D 2024-01-29 Common Stock 6181 0 D The exercise and sale reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The option vested with respect to 1/36th of the shares monthly from the grant date of January 29, 2014 such that option fully vested on the third anniversary of the grant date. /s/ Karah Parschauer, attorney-in-fact 2020-07-08